A study published in 2023 found that using sleeping pills to get some shut-eye could reduce the buildup of toxic clumps of ...
A secondary analysis of TRAILBLAZER-ALZ 2 strengthens the case that reducing amyloid plaques underlies the clinical benefits ...
Alzheimer's disease is notorious for scrambling patients' daily rhythms. Restless nights with little sleep and increased ...
Lecanemab is the first medication approved in Canada that targets the buildup of amyloid plaque in the brain, which is ...
Spanish and Chinese scientists say they have used nanoparticles to enable the brains of mice to clear out plaque linked to ...
Algal bloom triggered by sewage discharges could be causing in dolphins the same form of brain degeneration seen in humans ...
A new study has identified a mutation in the TREM2 gene that disrupts the brain’s ability to clear toxic amyloid plaques, ...
The FDA has cleared the Elecsys pTau181 test as an aid in early detection of amyloid pathology in the primary care setting for adults aged 55 years and older presenting with signs, symptoms or ...
Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today it will offer the Elecsys pTau181 test, the only blood test cleared by the U.S. Food and Drug ...
A new scientific report reveals that the protein aggregates associated with Parkinson’s disease are not inert clumps of ...
Alzheimer’s disease not only damages memory but also distorts the brain’s internal clock, disrupting the daily rhythms of hundreds of genes tied to brain health.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback